These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 29036837)

  • 21. Discontinuation of statin therapy associates with Parkinson disease: a population-based study.
    Lee YC; Lin CH; Wu RM; Lin MS; Lin JW; Chang CH; Lai MS
    Neurology; 2013 Jul; 81(5):410-6. PubMed ID: 23884037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.
    Nelson A; Torres DM; Morgan AE; Fincke C; Harrison SA
    J Clin Gastroenterol; 2009; 43(10):990-4. PubMed ID: 19448566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review.
    Al-Kuraishy HM; Fahad EH; Al-Windy S; El-Sherbeni SA; Negm WA; Batiha GE
    Inflammopharmacology; 2024 Apr; 32(2):917-925. PubMed ID: 38499742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
    Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
    Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease.
    Cheng KK; Swallow DM; Grosset KA; Grosset DG
    Scott Med J; 2017 Aug; 62(3):104-109. PubMed ID: 28836927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins in Parkinson's Disease: Influence on Motor Progression.
    Palermo G; Giannoni S; Giuntini M; Belli E; Frosini D; Siciliano G; Ceravolo R
    J Parkinsons Dis; 2021; 11(4):1651-1662. PubMed ID: 34275907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
    de Lemos JA; Blazing MA; Wiviott SD; Lewis EF; Fox KA; White HD; Rouleau JL; Pedersen TR; Gardner LH; Mukherjee R; Ramsey KE; Palmisano J; Bilheimer DW; Pfeffer MA; Califf RM; Braunwald E;
    JAMA; 2004 Sep; 292(11):1307-16. PubMed ID: 15337732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and Cognition in Parkinson's Disease.
    Deck BL; Rick J; Xie SX; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Trojanowski JQ; Weintraub D
    J Parkinsons Dis; 2017; 7(4):661-667. PubMed ID: 28922167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
    Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
    Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study).
    Craig TR; Duffy MJ; Shyamsundar M; McDowell C; O'Kane CM; Elborn JS; McAuley DF
    Am J Respir Crit Care Med; 2011 Mar; 183(5):620-6. PubMed ID: 20870757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin Use and Its Association with Essential Tremor and Parkinson's Disease.
    Shalaby SY; Louis ED
    Neuroepidemiology; 2016; 47(1):11-7. PubMed ID: 27304858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W; Phongtuntakul B
    J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of statin use with Parkinson's disease: Dose-response relationship.
    Jeong SM; Jang W; Shin DW
    Mov Disord; 2019 Jul; 34(7):1014-1021. PubMed ID: 30938893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date.
    Reiss AB; Wirkowski E
    Drugs; 2007; 67(15):2111-20. PubMed ID: 17927279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).
    Guymer RH; Dimitrov PN; Varsamidis M; Lim LL; Baird PN; Vingrys AJ; Robman L
    Clin Interv Aging; 2008; 3(3):581-93. PubMed ID: 18982929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats.
    Wang T; Cao X; Zhang T; Shi Q; Chen Z; Tang B
    Neurol Sci; 2015 Aug; 36(8):1397-402. PubMed ID: 25787808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
    Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.